Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    CA-4948

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 103Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Curis Closes Private Placement for Up to $80.8M in Gross Proceeds
    Curis Closes Private Placement for Up to $80.8M in Gross Proceeds

    10 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/curis-announces-closing-of-private-placement-totaling-up-to-80-8-million-in-gross-proceeds-302657173.html

    PR NEWSWIRE
    10 Jan 2026
    Share Share
    Curis to Host Conference Call and Webcast on November 6, 2025
    Curis to Host Conference Call and Webcast on November 6, 2025

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/curis-to-report-third-quarter-2025-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-6-2025-302600252.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    Curis Discloses Inducement Grants Per NASDAQ LR 5635(C)(4)
    Curis Discloses Inducement Grants Per NASDAQ LR 5635(C)(4)

    03 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/curis-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302575015.html

    PR NEWSWIRE
    03 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.